Abstract P1-18-04: CTCs and SUV to predict the efficacy of the bone-specific radiopharmaceutical agent radium-223 dichloride combined with hormonal therapy for hormone receptor-positive bone-dominant breast cancer metastasis
Year: 2019
Type: conference-abstract
Source: Cancer Research
Authors: NT Ueno, RK Tahara, JM Reuben, H Gao, B Saigal, T Fujii, A Lucci, NK Ibrahim, S Damodaran, Y Shen, DD Liu, GN Hortobagyi, D Tripathy, B Lim, BA Chasen
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2944459902